Stein Løkstad

Stein Løkstad is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Business Development at Q-VANT Biosciences since January 2022, where the focus is on innovative supply chain solutions for QS-21 and other Quillaja-based saponin adjuvants. In addition to this role, Stein has been an Executive Advisor at Stein ApS since March 2017, specializing in strategy and business development for global vaccine projects. Previous experience includes key leadership positions such as General Manager at Brenntag Biosector A/S, where responsibilities encompassed vision, strategy, and P&L management, as well as serving as Business Unit Director for Brenntag’s Healthcare division. Stein's extensive career is complemented by advisory roles and contributions to industry committees, including as Chairman of the Life Sciences Committee at FECC. Educational credentials include an International Executive Program at INSEAD, leadership training at Harvard Business School, and a Master’s degree in Political Science from the University of Bergen.